Robert I. Fox

16.3k total citations · 4 hit papers
137 papers, 12.6k citations indexed

About

Robert I. Fox is a scholar working on Physiology, Immunology and Rheumatology. According to data from OpenAlex, Robert I. Fox has authored 137 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Physiology, 39 papers in Immunology and 36 papers in Rheumatology. Recurrent topics in Robert I. Fox's work include Salivary Gland Disorders and Functions (63 papers), Systemic Lupus Erythematosus Research (22 papers) and Diabetes and associated disorders (19 papers). Robert I. Fox is often cited by papers focused on Salivary Gland Disorders and Functions (63 papers), Systemic Lupus Erythematosus Research (22 papers) and Diabetes and associated disorders (19 papers). Robert I. Fox collaborates with scholars based in United States, Japan and Germany. Robert I. Fox's co-authors include Michael E. Stern, Paul E. Michelśon, Michael E. Weinblatt, Ken J. Bulpitt, Joel M. Kremer, Daniel Burge, Arthur D. Bankhurst, M. Lange, Roy Fleischmann and Hoil Kang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert I. Fox

136 papers receiving 12.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

1999 1.6k citations Michael E. Weinblatt, Joel M. Kremer et al. New England Journal of Medicine profile →
Sjögren's syndrome

2005 1.3k citations Robert I. Fox The Lancet profile →
The Pathology of Dry Eye

1998 661 citations Robert I. Fox et al. profile →
Sjögren's syndrome. Proposed criteria for classification

1986 550 citations Robert I. Fox et al. Arthritis & Rheumatism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert I. Fox	4.4k	3.5k	3.1k	2.3k	2.2k	137	12.6k
Pierre Youinou	2.7k 0.6×	4.2k 1.2×	5.4k 1.7×	2.0k 0.9×	525 0.2×	476	12.6k
Haralampos Μ. Moutsopoulos	9.6k 2.2×	7.5k 2.2×	5.6k 1.8×	1.9k 0.8×	1.5k 0.7×	402	21.5k
Robert B. Nussenblatt	1.3k 0.3×	5.1k 1.5×	5.2k 1.7×	2.0k 0.9×	1.7k 0.8×	435	25.1k
C. Stephen Foster	1.4k 0.3×	5.4k 1.5×	1.5k 0.5×	3.4k 1.5×	3.7k 1.7×	579	20.0k
Cees G. M. Kallenberg	3.6k 0.8×	6.6k 1.9×	6.8k 2.2×	1.7k 0.7×	346 0.2×	369	18.0k
James T. Rosenbaum	1.9k 0.4×	5.2k 1.5×	2.7k 0.9×	1.3k 0.6×	994 0.5×	357	16.9k
Nathan J. Zvaifler	2.5k 0.6×	8.7k 2.5×	5.2k 1.7×	2.2k 0.9×	350 0.2×	170	20.0k
Brian L. Kotzin	984 0.2×	3.8k 1.1×	8.5k 2.7×	2.3k 1.0×	818 0.4×	175	13.5k
Fabienne Mackay	2.4k 0.6×	3.5k 1.0×	13.6k 4.4×	2.4k 1.0×	629 0.3×	146	22.2k
William Krivit	4.1k 0.9×	998 0.3×	1.9k 0.6×	333 0.1×	1.3k 0.6×	279	14.6k

Countries citing papers authored by Robert I. Fox

Since Specialization

Citations

This map shows the geographic impact of Robert I. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Fox more than expected).

Fields of papers citing papers by Robert I. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Fox. The network helps show where Robert I. Fox may publish in the future.

Co-authorship network of co-authors of Robert I. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Fox. A scholar is included among the top collaborators of Robert I. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Fox. Robert I. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dörner, Thomas, Simon Bowman, Robert I. Fox, et al.. (2024). Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study. Arthritis & Rheumatology. 77(5). 560–570. 3 indexed citations

Fox, Robert I., et al.. (2024). Rethinking Sjögren Beyond Inflammation: Considering the Role of Nerves in Driving Disease Manifestations. Eye & Contact Lens Science & Clinical Practice. 50(5). 200–207. 3 indexed citations

Fox, Robert I., et al.. (2023). Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials. Expert Opinion on Emerging Drugs. 28(2). 107–120. 6 indexed citations

Fox, Robert I., et al.. (2019). Treatment of Sjögren’s syndrome: current therapy and future directions. Lara D. Veeken. 60(5). 2066–2074. 69 indexed citations

Fox, Robert I.. (2005). Sjögren's syndrome. The Lancet. 366(9482). 321–331. 1308 indexed citations breakdown →

Fox, Robert I.. (2003). Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone. British journal of rheumatology. 42(8). 989–994. 34 indexed citations

Weinblatt, Michael E., Joel M. Kremer, Arthur D. Bankhurst, et al.. (1999). A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate. New England Journal of Medicine. 340(4). 253–259. 1612 indexed citations breakdown →

Fox, Robert I., Matthias Herrmann, Costakis Frangou, et al.. (1999). Mechanism of Action for Leflunomide in Rheumatoid Arthritis. Clinical Immunology. 93(3). 198–208. 312 indexed citations

Fox, Robert I., Jyrki Törnwall, & Paul E. Michelśon. (1999). Current issues in the diagnosis and treatment of Sjögrenʼs syndrome. Current Opinion in Rheumatology. 11(5). 364–371. 79 indexed citations

10.

Fox, Robert I. & Toshiaki Maruyama. (1997). Pathogenesis and treatment of Sj??gren??s syndrome. Current Opinion in Rheumatology. 9(5). 393–399. 55 indexed citations

11.

Fox, Robert I.. (1995). Vth International Symposium on Sjögren’s Syndrome Clinical Aspects and Therapy. Clinical Rheumatology. 14(S1). 17–19. 4 indexed citations

12.

Alpert, S., Hoil Kang, Irving L. Weissman, & Robert I. Fox. (1994). Expression of granzyme a in salivary gland biopsies from patients with primary sjögren's syndrome. Arthritis & Rheumatism. 37(7). 1046–1054. 40 indexed citations

13.

Pisa, Eva K., et al.. (1991). High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients.. The Journal of Experimental Medicine. 174(5). 1245–1250. 59 indexed citations

14.

Fox, Robert I., Mario Luppi, Hoil Kang, & Pavel Pisa. (1991). Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Seminars in Immunopathology. 13(2). 217–231. 46 indexed citations

15.

Ben‐Chetrit, Eldad, Robert I. Fox, & Eng M. Tan. (1990). Dissociation of immune responses to the ss‐a (ro) 52‐kd and 60‐kd polypeptides in systemic lupus erythematosus and sjögren's syndrome. Arthritis & Rheumatism. 33(3). 349–355. 126 indexed citations

16.

Cannon, Martin J., Pavel Pisa, Robert I. Fox, & Neil R. Cooper. (1990). Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.. Journal of Clinical Investigation. 85(4). 1333–1337. 131 indexed citations

17.

Saito, Ichiro, B Servenius, T Compton, & Robert I. Fox. (1989). Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome.. The Journal of Experimental Medicine. 169(6). 2191–2198. 346 indexed citations

18.

Chen, Pojen P., S Fong, Fernando Goñi, et al.. (1988). Cross-reacting idiotypes on cryoprecipitating rheumatoid factor. Springer Seminars in Immunopathology. 10(1). 35–55. 26 indexed citations

19.

Fox, Robert I., et al.. (1988). Treatment of primary Sjögren's syndrome with hydroxychloroquine. The American Journal of Medicine. 85(4). 62–67. 87 indexed citations

20.

Fox, Robert I., et al.. (1986). Characterization of a Crossreactive Idiotype in Sjögren’s Syndrome. Scandinavian Journal of Rheumatology. 15(sup61). 83–88. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact